Neuronetics and ANT Neuro Announce Strategic Collaboration to Integrate Neuronavigation with NeuroStar TMS Treatment

(NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders and the maker ...

MagVenture Receives FDA Clearance for Accelerated TMS Protocols, Expanding Flexibility for Clinics and Patients

ALPHARETTA, GA, UNITED STATES, May 26, 2026 /EINPresswire.com/ -- MagVenture®, a global leader in non-invasive ...

ZETA SURGICAL Announces First Commercial Deployment of Zeta TMS Navigation System at HOPE Therapeutics

ZETA SURGICAL today announced the first commercial deployment of its FDA-cleared Zeta TMS Navigation System. The system will ...
revistapesquisa.fapesp

Robotic platform makes transcranial magnetic stimulation treatment more precise

Transcranial magnetic stimulation (TMS) has proven to be a promising tool for research, diagnosis, and treatment of neurodegenerative diseases and psychiatric disorders such as depression, ...
PharmiWeb

Global Neuronavigation Systems Market to Reach USD 4794.5 Million by 2032 amid Rising Demand for Precision Neurosurgery | FMI

The global neuronavigation systems market is set for remarkable expansion, with projections estimating a market value of USD 4,794.5 million by 2032, up from USD 2,120.0 million in 2022. This surge is ...
Psychology Today

Could Accelerated TMS for Depression Become Standard?

Transcranial magnetic stimulation (TMS) was first approved for the treatment of major depressive disorder (MDD) in 2008. Because it worked well for depression by using a strong magnetic field to ...
Taiwan News

Neuronetics and ANT Neuro Announce Strategic Collaboration to Integrate Neuronavigation with NeuroStar TMS Treatment

First-of-its-kind partnership expands NeuroStar platform capabilities with advanced visualization technology designed to address evolving provider needs and support more personalized treatment ...